Article

A Computer Simulation of Employee Vaccination to Mitigate an Influenza Epidemic

University of Pittsburgh, 200 Meyran Avenue, Pittsburgh, PA 15213, USA.
American journal of preventive medicine (Impact Factor: 4.28). 03/2010; 38(3):247-57. DOI: 10.1016/j.amepre.2009.11.009
Source: PubMed

ABSTRACT Better understanding the possible effects of vaccinating employees is important and can help policymakers and businesses plan vaccine distribution and administration logistics, especially with the current H1N1 influenza vaccine in short supply.
This article aims to determine the effects of varying vaccine coverage, compliance, administration rates, prioritization, and timing among employees during an influenza pandemic.
As part of the H1N1 influenza planning efforts of the Models of Infectious Disease Agent Study network, an agent-based computer simulation model was developed for the Washington DC metropolitan region, encompassing five metropolitan statistical areas. Each simulation run involved introducing 100 infectious individuals to initiate a 1.3 reproductive-rate (R(0)) epidemic, consistent with H1N1 parameters to date. Another set of scenarios represented a R(0)=1.6 epidemic.
An unmitigated epidemic resulted in substantial productivity losses (a mean of $112.6 million for a serologic 15% attack rate and $193.8 million for a serologic 25% attack rate), even with the relatively low estimated mortality impact of H1N1. Although vaccinating Advisory Committee on Immunization Practices-defined priority groups resulted in the largest savings, vaccinating all remaining workers captured additional savings and, in fact, reduced healthcare workers' and critical infrastructure workers' chances of infection. Moreover, although employee vaccination compliance affected the epidemic, once 20% compliance was achieved, additional increases in compliance provided less incremental benefit. Even though a vast majority of the workplaces in the DC metropolitan region had fewer than 100 employees, focusing on vaccinating only those in larger firms (> or =100 employees) was just as effective in mitigating the epidemic as trying to vaccinate employees in all workplaces.
Timely vaccination of at least 20% of the large-company workforce can play an important role in epidemic mitigation.

Download full-text

Full-text

Available from: Philip Cooley, Aug 15, 2015
0 Followers
 · 
120 Views
  • Source
    • "One reason is that ABM are an important method for representing and describing interacting heterogeneous agents. Recently, they have been applied to H1N1 infectious disease applications [2] [3] [4] [5] [6] [7]. The heterogeneous property of agents enables ABM to describe more sophisticated and complex environments. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper describes the use of validation methods in model building. We address issues associated with the increasing complexity of models that is in part a response to the growing popularity of Agent-Based Models (ABM), commonly used to study cognitive, natural, and social phenomena. The first section of this manuscript discusses model categories and attributes. The second section discusses the stages of validating a simulation model: verification, validity, and sensitivity analysis. The third section presents specific validation approaches, with an emphasis on six specific tests that are described in detail. The final section summarizes the goals of model validation and modeling.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Simulation is widely used to investigate real-world systems in a large number of fields, including clinical trials for drug development, since real trials are costly, frequently fail and may lead to serious side effects. This paper is a survey of the statistical issues arising in these simulated trials. We illustrate the broad applicability of this investigation tool by means of examples selected from the literature. We discuss the aims and the peculiarities of the simulation models used in this context, including a brief mention of the use of metamodels. Of special interest is the topic of the design of the virtual experiments, stressing similarities and differences with the design of real life trials. Since it is important for a computerized model to possess a satisfactory range of accuracy consistent with its intended application, real data provided by physical experiments are used to confirm the simulator: we illustrate validating techniques through a number of examples. We end the paper with some challenging questions on the scientificity, ethics and effectiveness of simulation in the clinical research, and the interesting research problem of how to integrate simulated and physical experiments in a clinical context.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents an outline of a methodology for the design of nonlinear dynamic compensators for nonlinear multivariable systems with guarantees of closed-loop stability, robustness, and performance. The method is an extension of the Linear-Quadratic-Gaussian with Loop-Transfer-Recovery (LQG/LTR) methodology for linear systems, thus hinging upon the idea of constructing an approximate nonlinear inverse operator for the plant. A major feature of the method is a unification of both the state-space and Input-Output formulations. The major results of the paper are: i) Properties of the solution of certain optimal control problems; ii) New results on nonlinear estimation, including a new nonlinear observer with certain guaranteed properties; iii) The Loop Operator Recovery (LOR) procedure, and iv) Inclusion of command-following and disturbance rejection with a goal of a closed-loop stable, robust system.
    American Control Conference, 1985; 07/1985
Show more